Supporting TB recovery: The UPLIFT trial
Part of Infections clinical trials.
This trial is studying if offering extra support to people being treated for tuberculosis (TB) can help them recover and feel better overall. It's for people who have started treatment for drug-sensitive TB and live in certain areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with TB that is not resistant to drugs and it affects your lungs.
- This is your first time being treated for TB or you have had TB before and it has come back (relapse).
- You have started TB treatment and your case has been officially reported in the VITIMES system.
- You have been living in one of the study districts for at least the past month.
- You are the first person in your household to join this study.
- You are not planning to move to a different area in the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an online program to help people with tuberculosis feel less stigma and improve their health. It uses digital tools to provide support and might make living with the disease easier.
This trial tests whether adding dedicated nursing support in and out of the hospital helps people with tuberculosis complete their treatment and recover better.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This trial studies whether reminder-based “vDOT” and small economic incentives can help people complete treatment for latent (sleeping) tuberculosis. If you have latent TB and are starting a standard medicine plan, it may help you stay on track and finish safely.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.